Back

Rapid computed tomography coronary angiography (CTCA)

20 May 2024 (15:00 - 15:15)
Organised by: Logo
Congress Presentation Part of: Lessons from imaging trials in chronic CAD Nuclear Imaging Open Access International Conference on Nuclear Cardiology and Cardiac CT 2024 European Association of Cardiovascular Imaging (EACVI)

About the speaker

Photo
Professor David Newby

University of Edinburgh, Edinburgh (United Kingdom of Great Britain & Northern Ireland)

5 More presentations in this session

Presentation thumbnail
The role of perfusion imaging in real life: insights from the EURECA Registry
Doctor D. Neglia (Pisa, IT)
Slides
Presentation thumbnail
Coronary atherosclerotic plaque activity and events in the PREFFIR study
Professor M. Dweck (Edinburgh, GB)
Slides
Presentation thumbnail
Myocardial perfusion to predict abnormal FFR in known coronary artery disease (PACIFIC 1+2 studies)
Professor P. Knaapen (Amsterdam, NL)
Presentation thumbnail
Discharge trial
Professor P. Maurovich-Horvat (Budapest, HU)
Presentation thumbnail
Myocardial perfusion imaging after coronary computed tomography (Dan-NICAD study)
Doctor S. Winther (Herning, DK)
Slides

Access the full session

Session thumbnail
Lessons from imaging trials in chronic CAD

The Event

Event poster

International Conference on Nuclear Cardiology and Cardiac CT 2024

20 May 2024 15:00 CET
You may be interested in
thumbnail
Congress Presentation
CT coronary angiography in Selected Group of patients with Chest pain of new onset predicts and prevents hospital admissions & Outpatient Clinic referrals.
15 April 2021
thumbnail
Congress Presentation
Photon-counting and spectral CT beyond the coronaries
11 December 2025
thumbnail
Congress Presentation
A segment-to-segment agreement between findings of Cardiac Computed Tomography Angiography and invasive coronary artery angiography
27 August 2022
thumbnail
Congress Presentation
Incremental value of on-site computed tomography-derived fractional flow reserve for the diagnosis and management strategy of obstructive coronary artery disease in the randomized CRESCENT trials
3 September 2019

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources